PTC Therapeutics
PTCT
#2616
Rank
โ‚น643.37 B
Marketcap
โ‚น7,756
Share price
-2.82%
Change (1 day)
85.84%
Change (1 year)

PTC Therapeutics (PTCT) - Cash on Hand

Cash on Hand as of March 2026 : โ‚น178.89 Billion

According to PTC Therapeutics 's latest financial reports the company has โ‚น178.89 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

PTC Therapeutics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚น174.63 B78.62%
2024-12-31โ‚น97.77 B33.96%
2023-12-31โ‚น72.98 B114.76%
2022-12-31โ‚น33.98 B-40.96%
2021-12-31โ‚น57.56 B-28.68%
2020-12-31โ‚น80.71 B64.86%
2019-12-31โ‚น48.95 B207.66%
2018-12-31โ‚น15.91 B30.32%
2017-12-31โ‚น12.21 B-22.43%
2016-12-31โ‚น15.74 B-30.1%
2015-12-31โ‚น22.52 B12.73%
2014-12-31โ‚น19.97 B127%
2013-12-31โ‚น8.80 B5797.61%
2012-12-31โ‚น0.14 B-90.08%
2011-12-31โ‚น1.50 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
โ‚น659.53 B 268.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น685.03 B 282.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น51.77 B-71.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น61.74 B-65.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น20.36 B-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น160.40 B-10.34%๐Ÿ‡บ๐Ÿ‡ธ USA